Last Updated on March 28, 2025 by The Health Master
NPPA
Download NPPA notification No. S.O. 1094 (E) dt 05-03-2025, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 53 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 1094 (E) dt 05-03-2025 based on the decision of 130th Authority meeting dated 25-02-2025.
The notification states as follows:
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
A table is given below the article
Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.
The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules, including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
NPPA updated price lists: Download
Latest Notifications: EC Act (Essential Commodities Act)
NPPA revised retail price of 1 new formulation: February 2025
NPPA revised ceiling price of 2 formulations: February 2025
NPPA fixed retail price of 42 formulations: February 2025
NPPA fixed retail price of 7 formulations: December 2024
NPPA revised Ceiling price of 13 scheduled formulations: December 2024
DCC agrees with proposal to amend Rule 89 for better clarity
Gujarat Drug Inspectors Armed with Spectrophotometers for Instant Drug Tests
FDA Punjab to track manufacture and sale of these 7 drugs
OTC Medicines list coming this month: India
Drug recall: Glenmark recalls 15 lakh bottles of this Drug
Karnataka’s new NSQ Drug Recall Policy
New Drug Approval: DCGI Demands Uniformity
FSSAI: Food Labelling and Display – Chapter-15
Workshop on NDPS to combat the misuse of drugs: FDA Haryana
Table
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Acetylcysteine & Acebrophylline Tablets | Each film coated tablet contains: Acetylcysteine BP 600 mg Acebrophylline 100 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. /M/s Aurobindo Pharma Ltd. | 14.98 |
2 | Bisoprolol Fumarate & Amlodipine Besilate Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine Besilate eq. to Amlodipine IP 5 mg | 1 Tablet | M/s Swiss Garnier Life Sciences/ M/s Workcell Solutions Pvt. Ltd. | 8.54 |
3 | Cefixime & Ofloxacin Oral Suspension | Each 5 ml of the reconstituted suspension contains: Cefixime Trihydrate IP eq. to Cefixime anhydrous 50 mg Ofloxacin IP 50 mg | 1 ML | M/s Theon Pharmaceuticals Ltd. /M/s J.B Chemicals & Pharmaceuticals Ltd. | 2.00 |
4 | Cefixime Oral Suspension IP (Combipack with Sterile Water) | Each Combipack contains: Cefixime Oral Suspension IP Each 5 ml of reconstituted suspension contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200 mg 1 Vial of Sterile Water for Injections IP Each Vial Contains: Sterile Water for injections IP 30 ml | 1 ML | M/s Malik Lifesciences Pvt. Ltd./ M/s FDC Ltd. | 3.72 |
5 | Calcium Citrate Malate & Vitamin D3 Tablets | Each film coated tablet contains: Calcium Citrate Malate IP eq. to Elemental Calcium 250 mg Vitamin D3 IP 1000 IU | 1 Tablet | M/s Marine Medicare Pvt. Ltd. /M/s Alkem Laboratories Ltd. | 12.31 |
6 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine HCl & Vitamin D3 tablets | Each film coated tablet contains: Methylcobalamin IP 1500 mcg Alpha Lipoic Acid IP 100 mg Folic Acid IP 1.5 mg Pyridoxine HCl IP 3 mg Vitamin D3 IP 1000 IU | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. | 15.63 |
7 | Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate tablets | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine HCl IP 10 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s East African (India) Overseas/ M/s Micro Labs Ltd. | 4.81 |
8 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ML | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 1.29 |
9 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 1 mg | 1 ML | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 1.17 |
10 | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride tablets | Each film coated tablet contains: Dextromethorphan Hydrobromide IP 10 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine Hydrochloride IP 5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 4.78 |
11 | Paracetamol & Caffeine Tablets | Each uncoated tablet contains: Paracetamol IP 650mg Caffeine IP (Anhydrous) 50 mg | 1 Tablet | M/s Juggat Pharma (Pharma Division of Jagdale Industries Pvt. Ltd.) | 3.61 |
12 | Ibuprofen & Paracetamol Suspension | Each 5 ml contains: Ibuprofen IP 100 mg Paracetamol IP 162.5 mg | 1 ML | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd./ M/s Lupin Life Sciences Ltd. | 0.52 |
13 | Diclofenac sodium & Thiocolchicoside capsules | Each Hard Gelatin capsule contains: Diclofenac sodium IP 50 mg (as Diclofenac sodium Gastro- Resistant tablets IP) Thiocolchicoside IP 4 mg (as uncoated Thiocolchicoside tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Dr. Reddy’s Laboratories Ltd. | 16.90 |
14 | Domperidone & Naproxen Sodium Tablets | Each film coated tablet contains: Domperidone Maleate IP eq. to Domperidone 10 mg, Naproxen Sodium USP 550 mg eq. to Naproxen 500 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 8.49 |
15 | Escitalopram Oxalate & Clonazepam tablets | Each film coated tablet contains: Escitalopram Oxalate IP Eq. to Escitalopram 20mg Clonazepam IP 0.5mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Limited / M/s Lupin Limited | 19.65 |
16 | Escitalopram Oxalate & Clonazepam tablets | Each film coated tablet contains: Escitalopram Oxalate IP Eq. to Escitalopram 5 mg Clonazepam IP 0.25mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Limited / M/s Lupin Limited | 7.96 |
17 | Lactulose Enema | Each ml contains: Lactulose Solution IP eq. to Lactulose 200 mg Sodium Benzoate IP 3mg (as preservative) | 1 ML | M/s Naxpar Pharma Pvt. Ltd./ M/s Abbott India Ltd. | 1.32 |
18 | Mefenamic Acid & Tranexamic Acid Tablets | Each Film Coated Tablet contains: Mefenamic Acid IP 250 mg Tranexamic Acid IP 500 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Dr. Reddy’s Laboratories Ltd. | 33.25 |
19 | Nebivolol Hydrochloride & Telmisartan tablets | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. /M/s German Remedies Pharmaceuticals Pvt. Ltd. | 15.60 |
20 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended-release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.68 |
21 | Telmisartan, Cilnidipine & Metoprolol Succinate (ER) tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended- release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.80 |
22 | Telmisartan, Cilnidipine & Chlorthalidone tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 12.50 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s Cadila Pharmaceuticals Ltd. | 15.07 |
23 | Telmisartan, Cilnidipine & Metoprolol Succinate (ER) tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol tartrate 25 mg (as Extended-release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 10.96 |
24 | Telmisartan, Cilnidipine & Metoprolol succinate (ER) tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended-release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 13.68 |
25 | Vildagliptin (SR), Dapagliflozin & Metformin Hydrochloride (SR) tablets | Each film coated bilayered tablet contains: Vildagliptin IP 100 mg (as sustained release) Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500 mg (as sustained release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 12.50 |
26 | Dapagliflozin, Teneligliptin & Metformin Tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Teneligliptin Hydrobromide Hydrate IP eq to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg (as sustained release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 11.60 |
27 | Linagliptin, Dapagliflozin & Metformin Hydrochloride (sustained release) tablets | Each film coated bilayer tablet contains: Linagliptin 5 mgDapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metformin hydrochloride IP 500mg (As Sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd./ M/s Akumentis Healthcare Ltd. | 18.50 |
28 | Sitagliptin & Metformin Hydrochloride (Sustained Release) tablets | Each Film Coated Bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as sustained release form) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 13.50 |
29 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s Zydus Healthcare Ltd. | 11.83 |
30 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 11.83 |
31 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 8.03 |
32 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 850 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 7.13 |
33 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 6.24 |
34 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s Zydus Healthcare Ltd. | 19.01 |
35 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated tablet contains: Empagliflozin 12.5 mgMetformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s MSN Laboratories Pvt. Ltd./M/s USV Ltd. | 19.01 |
36 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated Bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 19.01 |
37 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Cadila Pharmaceuticals Ltd. | 19.01 |
38 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 13.38 |
39 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd. | 19.01 |
40 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Abbott Healthcare Pvt. Ltd. | 17.85 |
41 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Cadila Pharmaceuticals Ltd. | 18.10 |
42 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s USV Ltd. | 18.10 |
43 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 12.49 |
44 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mgMetformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/M/s Emcure Pharmaceuticals Ltd. | 18.10 |
45 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Intas Pharmaceuticals Ltd. | 10.71 |
46 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Abbott Healthcare Pvt. Ltd. | 14.28 |
47 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 850 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 12.94 |
48 | Dapagliflozin & Metoprolol Succinate (as extended release form) tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Metoprolol Succinate eq. to Metoprolol Tartrate (as extended release) 50 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Ltd. | 17.27 |
49 | Dapagliflozin & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate eq. to Metoprolol Tartrate 50 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Ajanta Pharma Ltd. | 17.14 |
50 | Dapagliflozin & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate eq. to Metoprolol Tartrate 50 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals /M/s Cipla Ltd. | 17.27 |
51 | Dapagliflozin & Metoprolol Succinate (as extended-release form) tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Metoprolol Succinate eq. to Metoprolol Tartrate (as extended release) 25 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Ltd. | 15.96 |
52 | Metformin oral Solution | Each 5 ml oral solution contains: Metformin Hydrochloride IP 500mg | 1 ML | M/s Eris Therapeutics Limited | 0.40 |
53 | Cefixime & Erdosteine Capsules | Each hard gelatin capsule contains: Cefixime IP eq. to Cefixime Anhydrous 200 mg Erdosteine 300 mg | 1 Capsule | M/s Macleods Pharmaceuticals Ltd. | 39.08 |
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: